Physical activity cuts mortality in colorectal cancer survivors

January 23, 2013
Physical activity cuts mortality in colorectal cancer survivors
For patients with invasive, non-metastatic colorectal cancer, increased recreational physical activity is associated with reduced all-cause mortality, while prolonged sedentary time correlates with increased all-cause mortality, according to a study published online Jan. 22 in the Journal of Clinical Oncology.

(HealthDay)—For patients with invasive, non-metastatic colorectal cancer, increased recreational physical activity is associated with reduced all-cause mortality, while prolonged sedentary time correlates with increased all-cause mortality, according to a study published online Jan. 22 in the Journal of Clinical Oncology.

Peter T. Campbell, Ph.D., from the National Home Office in Atlanta, and colleagues examined the correlation of pre-diagnosis and post-diagnosis recreational physical activity and sedentary leisure time with mortality among 2,293 adults diagnosed with invasive, non- from a cohort of adults without colorectal cancer at baseline.

During a maximum follow-up of 16.1 years after colorectal , the researchers found that 846 patients died—379 from colorectal cancer. Significantly lower all-cause mortality was seen for those who engaged in 8.75 or more metabolic equivalent (MET) hours per week of recreational activity versus less than 3.5 MET hours (relative risks for pre-diagnosis and post-diagnosis physical activity, 0.72 and 0.58, respectively). Higher all-cause mortality was seen for those who spent six or more hours per day of leisure time sitting compared with fewer than three hours per day (relative risks for pre-diagnosis and post-diagnosis sitting time, 1.36 and 1.27, respectively).

"In conclusion, this study supports public health recommendations for recreational physical activity and the avoidance of sedentary time among colorectal cancer survivors," the authors write.

Explore further: Statin use at cancer diagnosis linked to lower mortality

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Statin use at cancer diagnosis linked to lower mortality

November 8, 2012
(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Journal of Medicine.

Study finds colorectal cancer mortality dropping slower in African Americans

December 22, 2011
A new study finds that while colorectal cancer mortality rates dropped in the most recent two decades for every stage in both African Americans and whites, the decreases were smaller for African Americans, particularly for ...

Adherence to cancer surveillance guidelines varies

March 30, 2012
(HealthDay) -- Insured breast cancer survivors have high rates of guideline-recommended recurrence testing and non-recommended metastatic testing, while only about half of colorectal cancer survivors undergo recommended surveillance ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.